Psoriasis may up risk of melanoma, hematologic cancer

5 Tips for a Healthy Vacation
May 24, 2017
Early Treatment Equals Better Results for Rheumatoid Arthritis
May 25, 2017
Show all

Psoriasis may up risk of melanoma, hematologic cancer

Psoriasis might increase the risk of certain cancers.

Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

 Shivani P. Reddy, from the University of Illinois at Chicago College of Medicine, and colleagues assessed the risk of melanoma and hematologic cancers in patients with psoriasis.

The researchers found that patients with psoriasis had 1.53 times greater risk of developing a malignancy versus patients without psoriasis (P < 0.01). There were no significant differences in risk among patients receiving different treatments (topicals, phototherapy, systemics, or biologic agents). For patients who developed malignancy, survival did not differ among those with or without psoriasis.

“Patients with psoriasis may experience an elevated risk of melanoma and hematologic cancers, compared with the general population,” the authors write. “The risk is not increased by systemic or biologic psoriasis therapies.”

Read full article: Psoriasis may up risk of melanoma, hematologic cancer

Read Full Article: Psoriasis may up risk of melanoma, hematologic cancer

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.